Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Top Cited Papers
- 1 February 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Molecular Cell Biology
- Vol. 8 (2), 101-112
- https://doi.org/10.1038/nrm2101
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse modelNature Medicine, 2006
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive functionNature Neuroscience, 2004
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004
- Reconstitution of γ-secretase activityNature, 2003
- A γ‐secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafishEMBO Reports, 2002
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001
- Regulated Intramembrane Proteolysis: A Control Mechanism Conserved from Bacteria to HumansCell, 2000
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinBiochemical and Biophysical Research Communications, 1984
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984